SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-109426
Filing Date
2010-05-06
Accepted
2010-05-05 21:39:37
Documents
7
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 557189
2 LICENSE AGREEMENT dex1013.htm EX-10.13 158862
3 SUPPLY AGREEMENT dex1054.htm EX-10.54 144858
4 2010 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS dex1055.htm EX-10.55 5221
5 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 10127
6 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 10129
7 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5254
  Complete submission text file 0001193125-10-109426.txt   893023
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 10803745
SIC: 2834 Pharmaceutical Preparations